Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1108530.RAU5Uvq7I60DYfNrbtBGQLhv9hvXWG0NAx_t2sDT0WkMI130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108530.RAU5Uvq7I60DYfNrbtBGQLhv9hvXWG0NAx_t2sDT0WkMI130_provenance.
• NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108531.RAb6a_nCY4sQW12J9eQRhKrlKuQaH14XxwC24_16zepB0130_provenance.
• NP1108534.RAQDJ6cexowoy07EH_ujLt5dhaS8UUdf3W954YVwO_8gg130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108534.RAQDJ6cexowoy07EH_ujLt5dhaS8UUdf3W954YVwO_8gg130_provenance.
• NP342383.RAvRN7gCUIxvc2GrX08mSgwo7Jjm-j4FH6s6U79PL0ULQ130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342383.RAvRN7gCUIxvc2GrX08mSgwo7Jjm-j4FH6s6U79PL0ULQ130_provenance.
• NP1108532.RArKWe1JWAlmy5gP4gamoVTXyV6VtyYpz-_yIvBrKIiZo130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108532.RArKWe1JWAlmy5gP4gamoVTXyV6VtyYpz-_yIvBrKIiZo130_provenance.
• NP1108533.RAvFuJxGsPE0lYGWqqw8V1Yk9sc8HbRxIJdMcnyj8ewPc130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108533.RAvFuJxGsPE0lYGWqqw8V1Yk9sc8HbRxIJdMcnyj8ewPc130_provenance.
• NP1108535.RAsHZFSXqxyEVgi4P6ly1_Vc2OERYurDe8VxBkUiE-i7Q130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108535.RAsHZFSXqxyEVgi4P6ly1_Vc2OERYurDe8VxBkUiE-i7Q130_provenance.
• NP341629.RAxinfmFp9RQP3M_kZ1Dmli57dNt9lhj3BuEBhc1t_s8s130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341629.RAxinfmFp9RQP3M_kZ1Dmli57dNt9lhj3BuEBhc1t_s8s130_provenance.
• NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341746.RA1wkdAvg7cTAv-RhCp63K9GMKq1Xq_XXUZ17Vpmgyh88130_provenance.
• NP342669.RAPXPUVzfE7xNeZftgMwEAVnGbnRKaTphXsWmhG6iEqf0130_assertion description "[The objective of this study is to investigate the influence of the 5-HTTLPR (serotonin transporter-linked promoter region), cytochrome P450 2C19, and cytochrome P450 2D6 polymorphisms on escitalopram (ESC) and venlafaxine (VEN) responses in major depressive disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342669.RAPXPUVzfE7xNeZftgMwEAVnGbnRKaTphXsWmhG6iEqf0130_provenance.